Immunomodulatory Implant for Bone Morphogenesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for bone fusion and healing in orthopedic surgery face complications such as adverse reactions from high doses of biologic stimulants like BMP, disease transmission risks with allograft and xenograft products, and the challenges of autologous bone harvesting, necessitating a safer and more effective alternative.
Innovation Solution
A porous hydroxyapatite or beta-tricalcium phosphate implant with an outer layer containing immunomodulatory substances like lipopolysaccharide and lipoteichoic acid to activate the innate immune system, and an inner layer with interleukins to facilitate a sequential healing process, avoiding the need for autologous or allogenic materials and reducing the risk of adverse reactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If pharmacologic doses of BMP are used to facilitate bone fusion, then bone healing is enhanced, but severe inflammatory reactions and complications occur
Solution Approach 1:
The immune activation process is segmented into sequential phases: initial innate immune activation by LPS/LTA, followed by adaptive immune activation by protein antigens, and finally anti-inflammatory resolution by interleukins. This temporal segmentation allows controlled immune activation without overwhelming inflammation.
Solution Approach 2:
The patent changes the parameter of immune activation from direct pharmacologic stimulation (BMP) to indirect immune-mediated stimulation (antigens + interleukins). This parameter change transforms the mechanism from high-dose growth factor administration to controlled immune system engagement, reducing inflammatory complications.
2Quantity of substance
If autologous bone harvesting is performed to achieve bone fusion, then bone graft material is obtained, but complications at harvest site occur
Solution Approach 1:
The patent extracts the essential function of bone grafting (providing osteoinductive stimulus) from the problematic process of autologous harvesting. By using synthetic antigens and interleukins applied to an implant, the osteoinductive effect is achieved without extracting bone from the patient's own body, eliminating harvest site complications.
Solution Approach 2:
The patent creates a synthetic copy of the bone healing stimulus using immunomodulatory molecules (LPS, LTA, protein antigens, interleukins) that replicate the osteoinductive effect of autologous bone without requiring actual bone tissue. This synthetic analog achieves the same therapeutic goal without the drawbacks of tissue harvesting.
3Quantity of substance
If allograft or xenograft bone products are used to facilitate bone fusion, then bone graft material is provided, but disease transmission risk exists
Solution Approach 1:
The patent uses synthetic copies of immunomodulatory molecules (recombinant LPS, LTA, protein antigens, and interleukins) that replicate the osteoinductive function of bone grafts without containing actual biological tissue. This eliminates the risk of prion or viral transmission while maintaining the therapeutic effect.
Solution Approach 2:
The patent employs synthetic, non-living immunomodulatory molecules that can be manufactured aseptically and discarded after use, replacing the need for biologically complex, potentially infectious bone graft materials. These synthetic molecules have no risk of disease transmission and can be produced at lower cost.
4Productivity
If immunomodulatory molecules are applied to implant surface, then bone healing is enhanced, but manufacturing complexity increases
Solution Approach 1:
The immunomodulatory molecules (LPS, LTA, protein antigens, interleukins) are pre-applied to the implant surface during manufacturing, creating a ready-to-use product that requires no additional activation steps during surgery. This preliminary preparation simplifies the surgical procedure while maintaining enhanced bone healing benefits.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The implant effectively initiates and enhances bone healing by activating the innate immune system in a controlled manner, promoting rapid and robust bone fusion without the adverse effects associated with high-dose biologic stimulants or disease transmission risks, and is cost-effective for widespread use.
Implementation Method 1
an implant that activates the innate immune system in a sequential timed fashion to initiate and enhance bone healing and regeneration or fusion
Data Source
AI summary
A method of forming an immunomodulatory implant operatively arranged to chemotactically facilitate bone morphogenesis, the method including forming a matrix of a first material, the matrix including an outer surface, and a plurality of pores, and applying an antigen to the matrix, wherein the antigen including at least one of a bacterial antigen or a viral antigen.